Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04374734

Quantification of Radiological Pulmonary Involvement in Acute Respiratory Failure

SARS (Severe Acute Respiratory Syndrome) Clinical Trial

Official title:
Automated Quantification of Radiological Pulmonary Involvement in Acute Respiratory Failure

Clinical Trial Summary

Acute respiratory failure (ARF) is a common condition and a common reason for urgent medical consultation. Assessing the extent of respiratory impairment is important to improve the management of patients with ARF. When Acute respiratory failure is caused by pathology of the pulmonary parenchyma, quantification of pulmonary radiographic involvement may be a component of the initial assessment of severity. This radiographic quantification would only be usable in clinical routine if it can be automated and provide a real-time result. The objective of this work is to assess the feasibility of an automated technique for quantifying radiological lung damage in situations of known or potential ARF.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04374734
Study type Observational
Source University Hospital, Strasbourg, France
Contact
Status Completed
Phase
Start date April 5, 2020
Completion date June 30, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04615052 - Home-based Exercise in COVID-19 Survivors N/A
Completed NCT04720794 - A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion N/A
Enrolling by invitation NCT04659486 - Adolescents With COVID-19/MIS-C at HCFMUSP N/A
Completed NCT04784481 - Ivermectin Reproposing for Mild Stage COVID-19 Outpatients Phase 1/Phase 2
Recruiting NCT04584658 - Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)
Active, not recruiting NCT04558476 - Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation Phase 2
Withdrawn NCT04456426 - Characteristics of Patients With COVID-19 in Meta State, Colombia
Completed NCT04546581 - Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) Phase 3
Completed NCT04446429 - Anti-Androgen Treatment for COVID-19 N/A
Completed NCT04701710 - Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan Phase 1/Phase 2
Enrolling by invitation NCT05054075 - Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19 Phase 2
Withdrawn NCT04590274 - Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Phase 1
Completed NCT04644159 - Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]
Recruiting NCT04978025 - Colloidal Silver, Treatment of COVID-19 N/A
Enrolling by invitation NCT04540185 - A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 Phase 3
Recruiting NCT04497454 - Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19) N/A
Completed NCT04366908 - Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome Phase 2
Active, not recruiting NCT04390412 - Low Dose Radiotherapy in COVID-19 Pneumonia Phase 1/Phase 2
Terminated NCT04382391 - Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms N/A
Recruiting NCT04559113 - Methylprednisolone in COVID-19 Patients (Methyl19LGH) N/A